Towards a Better Understanding of Parkinson’s Disease: The Use of Novel Technologies & Big Data

Parkinson’s disease (PD) is the most common degenerative movement disorder, affecting one in 100 people over the age of 60. Despite this, little is known about the daily burden of living with PD, and no objective test for making a PD diagnosis currently exists. Mobile and wearable technologies have the potential to reveal unprecedented insights about the natural history of PD progression and help lay the foundation for personalized medicine. Many of the principles applied to PD can help inform the use of mobile and wearable technologies for other diseases such as TBI and PTSD. In this presentation, Lauren Bataille discussed The Michael J. Fox Foundation’s efforts around novel technologies and big data to gain a better understanding of the experience of those living with PD, and the impact that this research could have for disease management and therapeutic drug development for PD and other brain diseases.

Learn More

Webinar originally hosted Wednesday, March 23, 2016, at 12pm noon ET
Watch Webinar

About Lauren Bataille
Associate Director of Research Partnerships at The Michael J. Fox Foundation

Lauren Bataille joined The Michael J. Fox Foundation (MJFF) in August, 2015. In her role as Associate Director of Research Partnerships, she manages the Foundation’s mobile-technology projects as well as the development and implementation of new clinical studies utilizing smart phone apps and watches. Prior to joining MJFF, Lauren was the Director of Programs at Basic Health International, where she managed pilot programs and clinical trials focused on cervical cancer prevention in low-resource settings. Lauren graduated with an MS in Neuroscience & Behavior from the University of Massachusetts at Amherst, and holds a BA in Neuropsychology from the University of Massachusetts’s Commonwealth Honors College.

More Webinars

The Good, The Bad, and The Ugly: Quality Data in Basic Research
Animal Modeling 102 – Frameworks and Case Studies for Translational Model Systems of PTSD
Neural Circuit and Genomic Approaches to PTSD and Fear-Related Disorders
Showing Slide 1 of 4
Cohen Veterans Bioscience - Advancing Brain Health

An important message from CVB

From 2015–2024, Cohen Veterans Bioscience pioneered a new approach to researching PTSD and TBI.

CVB ceased operations in 2024.

This website is available for informational purposes only, providing details about our history and legacy.